The Therapeutic Effectiveness of Two Combined Regimens in Managing COVID-19 Pneumonia Patients: A Single-Center, Retrospective Observational Analysis
Abstract
Introduction: Currently, there is no established pharmaceutical treatment for coronavirus patients; however, therapeutic approaches are still being developed to assess effective treatments during this unprecedented COVID-19 pandemic. Moreover, it has been observed that combination therapy may improve the individual’s treatment output. The present study aimed to compare the effectiveness of two independent combination regimens to improve the health conditions of individuals infected with a novel coronavirus. Methods: The current study was a retrospective, single-centered observational study. It included 100 COVID-19-positive patients with age ≥18 years, all with confirmed positive laboratory results. The patients’ clinical and laboratory data were recorded. The participants were classified into two distinct groups based on the therapeutic regimens: group I received regimen I, which included azithromycin, favipiravir, clopidogrel, and acetaminophen, and group II received regimen II, which included ceftriaxone, levofloxacin, methylprednisolone, clopidogrel, and acetaminophen. Results and Discussion: Patients following regimen II showed improvements in white blood cell count (WBC) (P = 0), lymphocyte cells (P< 0.001), C-reactive protein (p< 0), and respiration rate (RR) (p<0.001). Despite a significant difference in the level of platelet count between the two groups, clinically significant changes were observed in temperature and SpO2 levels. Conclusion: This study indicated the…
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Levofloxacin-Induced Tendon Rupture: A Case Report and Review of the Literature
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
- Neuroprotective Effects of Epicatechin against Oxidative Stress-Induced Cognitive Impairment: A Systematic Review and Meta-Analysis
- Quality evaluation and in vitro interaction studies between levofloxacin 250mg and diclofenac sodium 50mg tablets
- Molecular Epidemiology of mcr-1 -Positive Polymyxin B-Resistant Escherichia coli Producing Extended-Spectrum β-Lactamase (ESBL) in a Tertiary Hospital in Shandong, China
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.